摘要
目的:了解血脂康对Ⅱ型糖尿病患者餐后血脂的影响。方法:选择已经确诊为Ⅱ型糖尿病伴高脂血患者52例,随机分为常规治疗组和血脂康治疗组。常规治疗组继续口服降糖药物,血脂康治疗组在口服降糖药的基础上加服血脂康0.6 g,早晚一次,两组同时接受饮食宣教。6周后进行高脂餐试验并测定餐前、后血脂。结果:血脂康治疗组高脂餐前、后血脂水平较治疗前有明显降低。结论:高脂餐后血清TG、TC、LDL-C浓度升高,血脂康有降低Ⅱ型糖尿病患者空腹及餐后血清TG、TC、LDL-C浓度和升高HDL浓度。
Objective： To investigate the effects of Xuezhikang on level of postprandial blood lipid of patients with type Ⅱ diabetes mellitus. Methods： 52 patients with type Ⅱ diabetes mellitus were divided randomly into two groups. One group（n=26, routine group） was treated with oral： hypnglycemie agent for 6 weeks and the other group（treated group） was treated with hypoglyeernie agent and Xuezhikang 1.2 g twice a day for 6 weeks. After treatment for 6 weeks, these patients received a high fat diet examination and their levels of preprandial and postprandial blood lipid were,measured, respaetively. Results： Compared with routine group, the levels of postprandial serum TC, TG and LDL - C in treated group decreased significantly（p〈0. 01）, TC from （6.42±0. 37） mmol/L to 5. 21± 0. 42） mmol/L, TG from （2. 12±0. 40） mmol/L to （1. 52±0.35） mmol/L and LDL - C from （4. 36±0. 49） mmol/L to （3. 65±0. 42） mmol/L. Conclusion： Xuezhikang is of a stronger hypolipidemie activity than.routine hypogtycemie agent.
出处
《西南国防医药》
CAS
2005年第6期607-608,共2页
Medical Journal of National Defending Forces in Southwest China
关键词
血脂康
Ⅱ型糖尿病
血脂
xuezhikang, diabetes mellitus, blood lipid, hypoglycemie agent
hypolipidemie drug
